KFS:NYSEKingsway Financial Services, Inc. Analysis
Data as of 2026-04-12 - not real-time
$11.36
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Kingsway Financial Services is trading well above its discounted cash‑flow estimate, with the market price more than three times the fair‑value figure, and a price‑to‑book ratio north of twenty, suggesting an overvalued valuation. The 20‑day simple moving average sits below the current price, while the 200‑day average remains higher, indicating a short‑term price lift but a longer‑term downtrend, reinforced by a bearish trend direction and a decreasing volume trend. Technical momentum is mixed: the MACD histogram is positive and the signal line is bullish, yet the MACD line remains below the signal, and the RSI hovers in the mid‑fifties, offering no clear overbought or oversold condition. Volatility is elevated at over forty percent for the past month, and beta is near one, implying market‑aligned risk.
Fundamentally, the company posted robust top‑line growth, with revenue expanding by roughly twenty‑eight percent year‑over‑year, and recent acquisitions have bolstered the top line further. However, operating margins are negative, the firm recorded a net loss in the latest quarter, and debt levels dwarf equity, resulting in an extreme debt‑to‑equity ratio. The news flow underscores profit pressure despite revenue gains and highlights the strategic acquisition strategy, but the lingering loss and high leverage temper optimism. With no dividend and cash flow deficits, sustainability concerns remain, while the high price‑to‑sales multiple further signals that the market may be pricing in future turnaround expectations.
Fundamentally, the company posted robust top‑line growth, with revenue expanding by roughly twenty‑eight percent year‑over‑year, and recent acquisitions have bolstered the top line further. However, operating margins are negative, the firm recorded a net loss in the latest quarter, and debt levels dwarf equity, resulting in an extreme debt‑to‑equity ratio. The news flow underscores profit pressure despite revenue gains and highlights the strategic acquisition strategy, but the lingering loss and high leverage temper optimism. With no dividend and cash flow deficits, sustainability concerns remain, while the high price‑to‑sales multiple further signals that the market may be pricing in future turnaround expectations.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Bearish technical trend with price near support
- Negative operating margins and net loss
- Significant overvaluation relative to DCF
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth and recent acquisitions
- Continued earnings pressure and high leverage
- Mixed technical signals and elevated volatility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for operational turnaround if margins improve
- Persistent debt burden limiting upside
- Sector cyclicality could provide upside in favorable economic cycles
Key Metrics & Analysis
Financial Health
Revenue Growth28.70%
Profit Margin-7.81%
ROE-38.90%
ROA-1.83%
Debt/Equity226.71
P/B Ratio21.4
Op. Cash Flow$-3000
Free Cash Flow$4.7M
Technical Analysis
TrendBearish
RSI55.5
Support$9.84
Resistance$11.80
MA 20$10.58
MA 50$11.66
MA 200$13.32
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$3.68
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.97
Volatility43.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.